Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-113907
Filing Date
2024-11-04
Accepted
2024-11-04 16:16:46
Documents
14
Effectiveness Date
2024-11-04

Document Format Files

Seq Description Document Type Size
1 S-8 tm2427253d2_s8.htm S-8 44400
2 EXHIBIT 23.1 tm2427253d2_ex23-1.htm EX-23.1 2586
3 EX-FILING FEES tm2427253d2_ex-filingfees.htm   iXBRL EX-FILING FEES 12780
  Complete submission text file 0001104659-24-113907.txt   187483

Data Files

Seq Description Document Type Size
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2427253d2_ex-filingfees_htm.xml XML 4790
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-282982 | Film No.: 241423787
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)